Company News: Merck (MRK) quarterly results miss analysts’ estimates

Market news

29 April 2021

Company News: Merck (MRK) quarterly results miss analysts’ estimates

Merck (MRK) reported Q1 FY 2021 earnings of $1.40 per share (versus $1.50 per share in Q1 FY 2020), missing analysts’ consensus estimate of $1.63 per share.

The company’s quarterly revenues amounted to $12.080 bln (+0.2% y/y), missing analysts’ consensus estimate of $12.709 bln.

The company also issued in-line guidance for FY 2021, projecting EPS of $6.48-6.88 versus analysts’ consensus estimate of $6.51 and revenues of $51.8-53.8 bln versus analysts’ consensus estimate of $52.11 bln.

MRK fell to $75.00 (-2.71%) in pre-market trading.

U.S. Dollar Index set to extend its slump behind FOMC's dovish tone - Westpac

EUR/USD: Strength to extend further to 1.2212 - Credit Suisse

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.